Popular on Amzeal
- From Courtroom to Coinstore: Gram Trading Launches, Marking Lantah's Defiant Trademark Victory
- Generative AI University and Small Business Results Unite to Help Entrepreneurs Optimize Marketing and Growth
- Letters Of Hope ! Postal Apocalypse #LettersOfHope
- Unmissable Lease-to-Own Opportunity: Luxury Home in Rotonda West with a Thriving Airbnb Business
- New Automated Platform Expands VSA's Omnichannel Capabilities
- THINKWARE Announces Labor Day Dash Cam Specials
- Tobu Railway Is Operating the "Oze Night Train 23:45" On Select Dates in August, September, and October 2024!
- DialCare Announces New Chief Information Officer
- Studica Robotics Products Listed as FIRST® Legal for the FTC 2024 INTO THE DEEP Competition
- EVO Solar Inverters in Stock: Celebrate the 15th Anniversary with New Product Launch
Similar on Amzeal
- Energies Media: Unifying Insights Across the Energy Spectrum
- DocVilla Introduces Best All-in-One Customizable Cloud-Based EHR Practice Management Software for Multi-Specialty and Small Practices
- MGN Logistics, Inc. and Arvo A.I. Ltd Forge Game-Changing Partnership to Supercharge Freight Management!
- TalentWell Launches Next Generation of AI-powered Talent Sourcing with Automated, Personalized Videos
- Health is for EveryBODY™ Campaign Partners with Chip In™
- Introducing REA's Innovative Program: PathFinder Coaching™
- Planned Spin-Out to Focus on Gene Therapy for Type 1 and 2 Diabetes in Parallel to Treatments for Late Stage Lung Cancer: Genprex: Stock Symbol: GNPX
- Black Women Talk Tech's 'Roadmap to Billions' Conference Debuts in Toronto – Empowering Black Women in Tech
- An Officer and Gentlewoman, LLC Hired as Public Relations Partner for The Annual Atlanta Fashion and Polo Classic
- 5 Reasons to Choose a Local Sonoma County Photographer
Micron Biomedical Expands World-Renowned Advisory Team with Appointment of Medtech Innovation Leader, Sandeep Patel, PhD Ahead of Commercial Manufacturing of Its Needle-Free Technology
Amzeal News/10574825
Immediate past Director of BARDA's Division of Research, Innovation and Ventures (DRIVe) and health innovation entrepreneur accepts first Board position with a stated mission to make vaccines and treatments more accessible
ATLANTA, Sept. 5, 2024 /PRNewswire/ -- Micron Biomedical, a life science company developing the world's first dissolvable, needle-free microarray-based products that could replace injectable pharmaceuticals and vaccines, today announced the appointment of former BARDA DRIVe Director, Dr. Sandeep Patel, to its Board of Advisors. In this capacity, Dr. Patel will bring his expertise in public health innovation to advance the commercialization of Micron Biomedical's unique technology. Recently, the company announced a grant to fund mass manufacturing of the technology following positive phase 1/2 data.
"Dr. Patel is well-known globally both for championing efficient, impactful and disruptive innovations that transform lives and for his creative, energetic and smart approach to advancing technologies he believes can make a significant and positive impact," said Steven Damon, CEO of Micron Biomedical. "We're thrilled he has decided to join Micron Biomedical as an advisor. As we demonstrate the ability to deliver medications and vaccines in a significantly more convenient, affordable and accessible way, our focus is on continued growth of our product portfolio and Dr. Patel's expertise is critical to our approach to getting needle-free technology into the hands of more people."
More on Amzeal News
Dr. Sandeep Patel was the first Director of BARDA's DRIVe, where he oversaw a diverse portfolio of high-risk, high-reward R&D programs to address existing and emerging health security threats. He also oversaw the development of the US government's first public-private venture capital partnership. Previously, Dr. Patel served in the Secretary's Office of the US Department of Health and Human Services (HHS) where he led multiple initiatives to advance innovative policies and funding solutions to complex, long-standing health problems.
"Globally, we must prioritize the development and commercialization of technologies and business models that can reduce barriers and improve access to vaccines and therapies," said Dr. Sandeep Patel. "There are a few players emerging but I believe Micron Biomedical can be a game-changer in bringing vaccines and therapies to more people around the world."
Dr. Patel joins a Board of Advisors that includes global health pioneer, Dr. Seth Berkley, who was announced as Scientific Advisor to the CEO earlier this year.
About Dr. Sandeep Patel
In addition to his leadership role at BARDA, Dr. Patel co-founded and led a public-private partnership, KidneyX, that catalyzed the development of breakthrough therapies for kidney disease, including renal replacement technologies. He spearheaded the Advancing American Kidney Health Initiative, aimed at reforming the nation's organ transplant system, getting more patients off dialysis, and increasing focus to prevent kidney failure. He led HHS' program to use novel methods, including incentive prizes and crowdsourcing, to solve complex health problems across the family of HHS agencies. He is the recipient of the American Society of Nephrology's President's Medal, and a Secretary's Distinguished Service award. Prior to that he was a Mirzayan Science and Technology Policy Fellow at the National Academy of Sciences.
More on Amzeal News
Dr. Patel holds a PhD in physical chemistry from the Georgia Institute of Technology and a BA in chemistry from Washington University in St. Louis.
About Micron Biomedical
Micron Biomedical is the leader in dissolvable microarray-based, drug and vaccine administration technology. Micron Biomedical is a clinical-stage life science company on a rapid path to commercializing its proprietary dissolvable, microarray technology. Micron's technology is designed to improve access and achieve better health outcomes globally through injection-free, painless, and simple and/or self-administration of drugs and vaccines, and by eliminating or reducing the need for cold chain transport and storage, enhancing safety and efficacy, and improving patient compliance. Micron partners with and/or receives funding from private and public pharmaceutical and biotech companies, the Bill & Melinda Gates Foundation, the Centers for Disease Control and Prevention (CDC), PATH and the Georgia Research Alliance. For more information visit www.micronbiomedical.com
Media Inquiries:
Chrystal Loyer
Cuttlefish Communications
+1 917 280 2498
[email protected]
SOURCE Micron Biomedical, Inc.
ATLANTA, Sept. 5, 2024 /PRNewswire/ -- Micron Biomedical, a life science company developing the world's first dissolvable, needle-free microarray-based products that could replace injectable pharmaceuticals and vaccines, today announced the appointment of former BARDA DRIVe Director, Dr. Sandeep Patel, to its Board of Advisors. In this capacity, Dr. Patel will bring his expertise in public health innovation to advance the commercialization of Micron Biomedical's unique technology. Recently, the company announced a grant to fund mass manufacturing of the technology following positive phase 1/2 data.
"Dr. Patel is well-known globally both for championing efficient, impactful and disruptive innovations that transform lives and for his creative, energetic and smart approach to advancing technologies he believes can make a significant and positive impact," said Steven Damon, CEO of Micron Biomedical. "We're thrilled he has decided to join Micron Biomedical as an advisor. As we demonstrate the ability to deliver medications and vaccines in a significantly more convenient, affordable and accessible way, our focus is on continued growth of our product portfolio and Dr. Patel's expertise is critical to our approach to getting needle-free technology into the hands of more people."
More on Amzeal News
- Life with Lucia and Glynn: A Global Duo Spreading Joy Through Matching Shirts and Adventures
- Luxury Real Estate Agent James Edmunds lists luxury beach home in the heart of Deerfield Beach
- Sycamore Hills Dentistry Welcomes the Yomi Robot: The Future of Dental Implant Surgery
- MGN Logistics, Inc. and Arvo A.I. Ltd Forge Game-Changing Partnership to Supercharge Freight Management!
- HFES Launches Refreshed Website Design for Inclusive Collaboration and Engagement
Dr. Sandeep Patel was the first Director of BARDA's DRIVe, where he oversaw a diverse portfolio of high-risk, high-reward R&D programs to address existing and emerging health security threats. He also oversaw the development of the US government's first public-private venture capital partnership. Previously, Dr. Patel served in the Secretary's Office of the US Department of Health and Human Services (HHS) where he led multiple initiatives to advance innovative policies and funding solutions to complex, long-standing health problems.
"Globally, we must prioritize the development and commercialization of technologies and business models that can reduce barriers and improve access to vaccines and therapies," said Dr. Sandeep Patel. "There are a few players emerging but I believe Micron Biomedical can be a game-changer in bringing vaccines and therapies to more people around the world."
Dr. Patel joins a Board of Advisors that includes global health pioneer, Dr. Seth Berkley, who was announced as Scientific Advisor to the CEO earlier this year.
About Dr. Sandeep Patel
In addition to his leadership role at BARDA, Dr. Patel co-founded and led a public-private partnership, KidneyX, that catalyzed the development of breakthrough therapies for kidney disease, including renal replacement technologies. He spearheaded the Advancing American Kidney Health Initiative, aimed at reforming the nation's organ transplant system, getting more patients off dialysis, and increasing focus to prevent kidney failure. He led HHS' program to use novel methods, including incentive prizes and crowdsourcing, to solve complex health problems across the family of HHS agencies. He is the recipient of the American Society of Nephrology's President's Medal, and a Secretary's Distinguished Service award. Prior to that he was a Mirzayan Science and Technology Policy Fellow at the National Academy of Sciences.
More on Amzeal News
- Take care of your pregnancy health with us
- The Kendall Project Accelerating AI Roadmapping Efforts Across Key Industries
- Jenni Lee Launches Kona Houses For Sale, Offering Comprehensive Real Estate Services in Kona, Hawaii and Surrounding Areas
- Cooking with Claudine Re-Launches in September with Fresh, Organic, and Gluten-Free Meal Delivery in the San Francisco Bay Area
- TalentWell Launches Next Generation of AI-powered Talent Sourcing with Automated, Personalized Videos
Dr. Patel holds a PhD in physical chemistry from the Georgia Institute of Technology and a BA in chemistry from Washington University in St. Louis.
About Micron Biomedical
Micron Biomedical is the leader in dissolvable microarray-based, drug and vaccine administration technology. Micron Biomedical is a clinical-stage life science company on a rapid path to commercializing its proprietary dissolvable, microarray technology. Micron's technology is designed to improve access and achieve better health outcomes globally through injection-free, painless, and simple and/or self-administration of drugs and vaccines, and by eliminating or reducing the need for cold chain transport and storage, enhancing safety and efficacy, and improving patient compliance. Micron partners with and/or receives funding from private and public pharmaceutical and biotech companies, the Bill & Melinda Gates Foundation, the Centers for Disease Control and Prevention (CDC), PATH and the Georgia Research Alliance. For more information visit www.micronbiomedical.com
Media Inquiries:
Chrystal Loyer
Cuttlefish Communications
+1 917 280 2498
[email protected]
SOURCE Micron Biomedical, Inc.
Filed Under: Business
0 Comments
Latest on Amzeal News
- BroadSource EMU Calling and Provisioning Protection (CAPP)
- SteepleMate Unveils AI-Powered Assist Tool to Revolutionize Church Management
- Women of Color STEM Conference Launches Inaugural Impact Awards
- VisualOn and Norlys Mark 10 Years of OTT Innovation, Reach Samsung Smart TV Integration Milestone
- Lineus Medical Announces a Reduction in Price for SafeBreak Vascular
- Finance Mentor: Revolutionizing Financial Coaching
- Empowering Artistry: The Fierce Feminine of ReFi Collection Debuts
- Youth Mental Health Abuse: Drugs, Sexual Assault, and Electroshock Exposed
- The Misfits Magazine Makes it Debut
- Oliver Sean's "Mama Taught Me (Dance Mix)" Featuring DJ Xquizit Hits #1 in Multiple Countries Within 24 Hours of Release
- Epic Fit Fest Celebrates Diversity, Wellness, and Community in Grand Prairie, Texas
- New Jersey Pediatric Neuroscience Institute Opens State-of-the-Art Pediatric Neuroscience Center in Hamilton, NJ
- THINKWARE Announces Labor Day Dash Cam Specials
- Black Women Talk Tech's 'Roadmap to Billions' Conference Debuts in Toronto – Empowering Black Women in Tech
- Kaplan Morrell Named Exclusive Workers' Compensation Firm for Greeley Police Officers Association
- Hoffman Homes Unveils New Brand
- Hanover Area YMCA Academy of Early Learning Awarded ECHO Innovation Grant
- An Officer and Gentlewoman, LLC Hired as Public Relations Partner for The Annual Atlanta Fashion and Polo Classic
- Point Source Audio Partners w/ Industry Leaders to Explore Theatre Miking Techniques in New Webinar
- EXPOSE Summer Youth Program Provides a Host of Benefits to High School Students